{"id":40481,"date":"2003-07-01T12:00:00","date_gmt":"2003-07-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie"},"modified":"2003-07-01T12:00:00","modified_gmt":"2003-07-01T10:00:00","slug":"neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/","title":{"rendered":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie"},"content":{"rendered":"<p>K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[954,326,3121,1279,1280,1281,338,339,1282,1283,340,341,4163,342,343,81,80,82,949,4633,1080,936,818,329,362,2285,1630,1631,331,5521,2577,1084,6543,345,815,3289,333],"class_list":["post-40481","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-adipositas","tag-alkohol","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-blutdruck","tag-dash-diaet","tag-diaet","tag-diuretika","tag-ernaehrung","tag-gewichtsreduktion","tag-hypertonie","tag-kalziumantagonisten","tag-kochsalz","tag-kochsalzreduktion","tag-koerpergewicht","tag-koerperliche-aktivitaet","tag-lebensstil","tag-lifestyle","tag-salzreduktion","tag-sartane","tag-spironolacton","tag-thiazide","tag-uebergewicht"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2003-07-01T10:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie\",\"datePublished\":\"2003-07-01T10:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/\"},\"wordCount\":973,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/07\\\/Abbildung-2003-51-2.gif\",\"keywords\":[\"ACE-Hemmer\",\"Adipositas\",\"Alkohol\",\"Angiotensin-II-Antagonisten\",\"Angiotensin-II-Blocker\",\"Angiotensin-II-Inhibitoren\",\"Angiotensin-II-Rezeptor-Antagonisten\",\"Angiotensin-II-Rezeptor-Blocker\",\"Angiotensin-II-Rezeptor-Inhibitoren\",\"AT-II-Antagonisten\",\"AT-II-Blocker\",\"AT-II-Inhibitoren\",\"AT-II-Rezeptor-Antagonisten\",\"AT-II-Rezeptor-Blocker\",\"AT-II-Rezeptor-Inhibitoren\",\"Beta-Blocker\",\"Betablocker\",\"Betarezeptoren-Blocker\",\"Blutdruck\",\"DASH-Di\u00e4t\",\"Di\u00e4t\",\"Diuretika\",\"Ern\u00e4hrung\",\"Gewichtsreduktion\",\"Hypertonie\",\"Kalziumantagonisten\",\"Kochsalz\",\"Kochsalzreduktion\",\"K\u00f6rpergewicht\",\"K\u00f6rperliche Aktivit\u00e4t\",\"Lebensstil\",\"Lifestyle\",\"Salzreduktion\",\"Sartane\",\"Spironolacton\",\"Thiazide\",\"\u00dcbergewicht\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/\",\"name\":\"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/07\\\/Abbildung-2003-51-2.gif\",\"datePublished\":\"2003-07-01T10:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/07\\\/Abbildung-2003-51-2.gif\",\"contentUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/07\\\/Abbildung-2003-51-2.gif\",\"width\":500,\"height\":169},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/","og_locale":"de_DE","og_type":"article","og_title":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief","og_description":"K\u00fcrzlich ist der 7. Report des US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) erschienen (1). \u00dcber den Vorg\u00e4nger-Report (JNC VI) haben wir 1997 ausf\u00fchrlich berichtet (2). In der Zwischenzeit sind mehrere wichtige klinische Studien zur Behandlung der Hypertonie und zu Erkrankungen, die sie h\u00e4ufig begleiten (Herzinsuffizienz, [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2003-07-01T10:00:00+00:00","og_image":[{"url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie","datePublished":"2003-07-01T10:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/"},"wordCount":973,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif","keywords":["ACE-Hemmer","Adipositas","Alkohol","Angiotensin-II-Antagonisten","Angiotensin-II-Blocker","Angiotensin-II-Inhibitoren","Angiotensin-II-Rezeptor-Antagonisten","Angiotensin-II-Rezeptor-Blocker","Angiotensin-II-Rezeptor-Inhibitoren","AT-II-Antagonisten","AT-II-Blocker","AT-II-Inhibitoren","AT-II-Rezeptor-Antagonisten","AT-II-Rezeptor-Blocker","AT-II-Rezeptor-Inhibitoren","Beta-Blocker","Betablocker","Betarezeptoren-Blocker","Blutdruck","DASH-Di\u00e4t","Di\u00e4t","Diuretika","Ern\u00e4hrung","Gewichtsreduktion","Hypertonie","Kalziumantagonisten","Kochsalz","Kochsalzreduktion","K\u00f6rpergewicht","K\u00f6rperliche Aktivit\u00e4t","Lebensstil","Lifestyle","Salzreduktion","Sartane","Spironolacton","Thiazide","\u00dcbergewicht"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/","name":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif","datePublished":"2003-07-01T10:00:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#primaryimage","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif","contentUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/07\/Abbildung-2003-51-2.gif","width":500,"height":169},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-empfehlungen-zur-behandlung-der-arteriellen-hypertonie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Neue Empfehlungen zur Behandlung der arteriellen Hypertonie"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=40481"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40481\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=40481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=40481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=40481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}